Reprogramming Synthetic Cells for Targeted Cancer Therapy. (2022)

First Author: Lim B

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acssynbio.1c00631

PubMed Identifier: 35255684

Publication URI: http://europepmc.org/abstract/MED/35255684

Type: Journal Article/Review

Volume: 11

Parent Publication: ACS synthetic biology

Issue: 3

ISSN: 2161-5063